Illustrasjonsfoto

Illustrasjonsfoto

  • Sist endret: 10.07.2014
  • Sist revidert: 10.07.2014

Vil du vite mer?

Dette dokumentet er basert på det profesjonelle dokumentet "Migrene" i Norsk Elektronisk Legehåndbok. Referanselisten for dette dokumentet vises nedenfor.

Referanser

  1. Silberstein SD. Migraine. Lancet 2004; 363: 381-91. PubMed
  2. Linde M, Stovner LJ, Zwart JA, Hagen K.Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia. 2011 Apr;31(5):585-96 PubMed
  3. Hagen K. Genetiske aspekter ved migrene. Tidsskr Nor Lægeforen 2003; 123: 2727-30. Tidsskriftet
  4. Alstadhaug KB, Salvesen R. Migrenesmerte - mekanismer og konsekvenser for behandling. Tidsskr Nor Lægeforen 2007; 127: 3064-8. Tidsskriftet
  5. Romanello S, Spiri D, Marcuzzi E, et al. Association between childhood migraine and history of infantile colic. JAMA 2013; 309: 1607-12. doi:10.1001/jama.2013.747. DOI
  6. Salvesen R. Nyere synspunkter på etiologi og patofysiologi ved migrene. Tidsskr Nor Lægeforen 1999; 119: 1437-43 PubMed
  7. Brandes JL. The influence of estrogen on migraine. JAMA 2006; 295: 1824-30. JAMA
  8. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine. Ann Neurol 1981; 9: 344-52. PubMed
  9. Headache Classification Committee. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004; 24: 28-36. PubMed
  10. Stewart W, Staffa J, Lipton R, Ottmann R. Familial risk of migraine: a population based study. Ann Neurol 1997; 41: 166-72. PubMed
  11. Fasmer OB, Oedegaard KJ. Migrene og psykiske lidelser. Tidsskr Nor Lægeforen 2004; 124: 2350-3. Tidsskriftet
  12. Silberstein SD, Young WB. Migraine aura and prodrome. Semin Neurol 1995; 45: 175-82. PubMed
  13. Giffin NJ, Ruggiero L, Lipton RB, et al. A novel approach to the study of premonitory symptoms in migraine using an electronic diary. Neurology 2003; 60: 935-40. Neurology
  14. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994; 44: 6-16..
  15. Thomsen LL, Eriksen MK, Roemer SF, Anderson I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125: 1379-99. PubMed
  16. Hershey LA, Bednarczyk EM. Treatment of headache in the elderly. Curr Treat Options Neurol. Oct 2012.
  17. Stewart WF, Schechter A, Lipton RB. Migraine heterogeneity: disability, pain intensity, attack frequency, and duration. Neurology 1994; 44 :(suppl) S24-39.
  18. Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 1995; 35: 387-96. PubMed
  19. Kaniecki RG. Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology 2002; 58(suppl 6): S15-20.
  20. Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician 2011; 83: 271-80. AFP
  21. Matchar DB, Young WB, Rosenberg JA, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. http://www.aan.com, 2000 (accessed April 25, 2000).
  22. Duncan CW, Watson DPB, Stein A, et al. Diagnosis and management of headache in adults; summary of SIGN guideline. BMJ 2008; 337: a2329. BMJ
  23. Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013; 4: CD008039. pmid:23633348 PubMed
  24. Kirthi V, Derry S, Moore RA. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013 Apr 30;4:CD008041. Cochrane
  25. Derry S, Moore RA, McQuay HJ. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013. CD008040. doi:10.1002/14651858.CD008040.pub3 DOI
  26. Lipton RB, Stewart WF, Stone AM, Lainez MJA, Sawyer JPC. Stratified care vs step care strategies for migraine. The disability in strategies of care (DISC) study: a randomized trial. JAMA 2000; 284: 2599-605. JAMA
  27. Lipton RB, Cady RK, O'Quinn S, Hall CB, Stewart WF. Sumatriptan treats the full spectrum of headache in individuals with disabling IHS migraine. Headache 1999; 40: 783-91. PubMed
  28. Law S, Derry S, Moore RA. Sumatriptan plus naproxen for acute migraine attacks in adults. Cochrane Database Syst Rev. 2013;10:CD008541. doi: 10.1002/14651858.CD008541.pub2. DOI
  29. Derry CJ, Derry S, Moore RA. Sumatriptan (all routes of administration) for acute migraine attacks in adults - overview of Cochrane reviews. Cochrane Database Syst Rev. 2014 28. DOI: 10.1002/14651858.CD009108.pub2. DOI
  30. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001; 358: 1668-75. PubMed
  31. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007; 297: 1443-54. JAMA
  32. Salvesen R. Valg av triptan ved migrene. Tidsskr Nor Lægeforen 2001; 121: 3410-1. Tidsskriftet
  33. Bird S, Derry S, Moore RA. Zolmitriptan for acute migraine attacks in adults. Cochrane Database of Syst Rev 2014; 5: CD008616. DOI: 10.1002/14651858.CD008616.pub2. DOI
  34. Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.. Headache 2006; 46: 212-22. PubMed
  35. Tfelt-Hansen P, Iversen HK. Triptaner i migrænebehandlingen. Ugeskr Læger 2006; 168: 1850-3. Ugeskrift
  36. Gaist D. Use and overuse of sumatriptan. Cephalalgia 1999; 19: 735-61. PubMed
  37. Hagen K, Stovner LJ. Migrenebehandling ved graviditet og amming. Tidsskr Nor Lægeforen 2006; 126: 3107-9. Tidsskriftet
  38. Mørch-Johnsen G, Myhr K. Behandling av migrene i svangerskapet. RELIS database 2012; : .
  39. Colman I, Friedman BW, Brown MD et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence . BMJ 2008; 336: 1359-61. BMJ
  40. Singh A, Alter HJ, Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Acad Emerg Med 2008; 15: 1223-33. PubMed
  41. Contag SA, Bushnell C. Contemporary management of migrainous disorders in pregnancy. Curr Opin Obstet Gynecol 2010; 22: 437-45. PubMed
  42. Cassina M, De Gianantonio E et al. Migraine therapy during pregnancy and lactation. Expert Opin Drug Saf 2010; 9: 937-48. PubMed
  43. Evans EW, Lorber KC. Use of 5-HT1 agonists in pregnancy. Ann Pharmacother 2008; 42: 543-9. PubMed
  44. Johansen JS, Stenberg-Nilsen H (RELIS). . Behandling av migrene i svangerskapet. Nyhetsbrev publisert 15.11.10.
  45. Källén K, Winbladh B. Läkemedel och fosterskador. Propranolol. http://www.janusinfo.se/gravreg/ (Sist endret: juni 2010).
  46. Lee MJ, Guinn D et al. Headache in pregnancy. UpToDate, last updated Mars 19. 2010. UpToDate
  47. Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults. Neurology 2012; 78: 1337-45. Neurology
  48. Holland S, Silberstein SD Freitag F, et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology 2012; 78: 1346-53. Neurology
  49. Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev 2004; (3): CD003226. Cochrane
  50. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004; 291: 965-73. JAMA
  51. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003; 289: 65-9. JAMA
  52. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician 2006; 73: 72-8. AFP
  53. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin-converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001; 322: 19-22. BMJ
  54. Ramadan NM, Schultz LL, Gikey SJ. Migraine prophylactic drugs: proof of efficacy, utlilization and cost. Cephalalgia 1997; 17:73-80. PubMed
  55. Kvan E, Narum S. P-piller med forlenget syklus - et fremskritt?. Tidsskr Nor Lægeforen 2005; 125: 2202-3. Tidsskriftet
  56. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010; 30: 804-14. PubMed
  57. Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta‐analysis. JAMA.2012;307:1737‐1745
  58. Linde M, Mulleners WM, Chronicle EP, et al. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 2013; 6: CD010609. doi:10.1002/14651858.CD010609 DOI
  59. Linde K, Allais G, Brinkhaus B, et al. Acupuncture for migraine prophylaxis. Cochrane Database of Systematic Reviews 2009; 1: CD001218. Cochrane
  60. Agency for Health Care Policy and Research, Duke University, Center for Clinical Health Policy Research. Behavioral and physical treatments for migraine headache, technical review 2.2. Rockville, Md.: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1999.
  61. Andrasik F. What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci 2007; 28(suppl 2): 70-7.
  62. Blanchard EB, Andrasik F, Ahles TA, Teders SJ, O'Keefe D. Migraine and tension-type headache: a meta- analytic review. Behav Ther 1980; 11: 613-31. PubMed
  63. Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain 1990; 42: 1-13. PubMed
  64. Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991; 31: 333-40. PubMed
  65. Campbell JK, Penzien DB, Wall EM, for the U.S. Headache Consortium. Evidence-based guidelines for migraine headache: behavioral and physical treatments. Accessed May 18, 2007, at: http://www.aan.com/professionals/practice/pdfs/gl0089.pdf
  66. Hermann C, Blanchard EB. Biofeedback in the treatment of headache and other childhood pain. Appl Psychophysiol Biofeedback 2002; 27: 143-62. PubMed
  67. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 754-62. Neurology
  68. Etminan M, Takkouche B, Isorna F, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005; 330: 63-5. BMJ
  69. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA 2006; 296: 283-91. JAMA
  70. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009; 301: 2563-70. JAMA
  71. Kurth T, Kase CS, Schürks M, et al. Migraine and risk of haemorrhagisk stroke in women: prospective cohort study. BMJ 2010; 341: c3659. BMJ
  72. Kurth T, Schurks M, Logroscino G et al. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008; 337: a636. BMJ
  73. Gudmundsson LS, Scher AI, Aspelund T, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ 2010; 341: c3966. BMJ
  74. Rothrock JF. Clinical studies of valproate for migraine prophylaxis. Cephalalgia 1997; 17:81-3 PubMed
  75. Taggart E, Doran S, Kokotillo A, et al. Ketorolac in the treatment of acute migraine: a systematic review. Headache 2013. doi:10.1111/head.12009 DOI
  76. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine: the population-based MRI CAMERA-study. Brain 2005; 128: 2068-77. PubMed

Debattregler

Relaterte artikler

Relaterte artikler

Migrene, oversikt

Migrene er anfall med ensidig, pulserende hodepine som varer 4-72 timer....

Migrene hos kvinner

Blant ungdommer og voksne er det to til tre ganger så mange kvinner som menn som har migrene.

Migrene, behandling

Det finnes flere måter å behandle migrene på. Hva som passer best for deg, avhenger ...

Migrene, årsaker

Det er fortsatt mye som er uklart omkring de kompliserte prosessene som skjer i ...

Cluster-hodepine

Cluster-hodepine er en sjelden sykdom som kjennetegnes ved kraftig, skjærende ...

NHI.no - Norges største helsenettside. Basert på Nordens mest brukte oppslagsverk for leger og helsepersonell (Norsk Elektronisk Legehåndbok).

©2011 Norsk Helseinformatikk AS. Alle rettigheter er reservert. All informasjon på NHI.no er laget for å gi deg generell kunnskap og er ingen erstatning for innhenting av medisinsk råd eller behandling hos helsepersonell. Dersom du er syk eller trenger medisinsk hjelp av andre grunner, bør du oppsøke lege. NHI er uten ansvar for innholdet på eksterne websteder det er lenket til. Vi tillater ikke reklame for behandlere/ behandlingsmetoder i kommentarfeltene. Alle slike innlegg vil bli slettet.